273 related articles for article (PubMed ID: 28628392)
1. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
5. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
6. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
Rodrigues J; Marques P; Gomes C; Portela C
Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
[TBL] [Abstract][Full Text] [Related]
7. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
8. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
Eyal S; Rasaby S; Ekstein D
Epilepsy Behav; 2014 Feb; 31():369-76. PubMed ID: 24211058
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
10. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant drug-drug interactions among elderly people with dementia.
Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
13. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
15. Assessing patients' information needs regarding drug-drug interactions.
Mutebi A; Warholak TL; Hines LE; Plummer R; Malone DC
J Am Pharm Assoc (2003); 2013; 53(1):39-45. PubMed ID: 23636154
[TBL] [Abstract][Full Text] [Related]
16. Severity and management of drug-drug interactions in acute geriatric patients.
Lea M; Rognan SE; Koristovic R; Wyller TB; Molden E
Drugs Aging; 2013 Sep; 30(9):721-7. PubMed ID: 23681400
[TBL] [Abstract][Full Text] [Related]
17. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
[TBL] [Abstract][Full Text] [Related]
18. Over-the-counter medications and cancer patients: growing awareness of drug-drug interactions.
Hanigan MH
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):105-7. PubMed ID: 19199376
[No Abstract] [Full Text] [Related]
19. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
20. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
